Table 2. Characteristics of patients by the five-gene-based classifier assessment set.
| TCGA LUAD (N=574) | GSE50081 (Adenocarcinoma N=127) | GSE42127 (Adenocarcinoma N=133) | GSE42127 (Squamous N=43) | |
|---|---|---|---|---|
| Age (Years, mean ± std) | 65.52 ± 9.91 | 68.73 ± 9.71 | 65.76 ± 10.29 | 68.11 ± 7.76 |
| Gender | ||||
| MALE | 238 | 62 | 65 | 18 |
| FEMALE | 272 | 65 | 68 | 25 |
| Stage | ||||
| I | 5 | 0 | 0 | 0 |
| IA | 132 | 36 | 32 | 10 |
| IB | 134 | 56 | 57 | 13 |
| II | 1 | 0 | 0 | 0 |
| IIA | 50 | 7 | 6 | 3 |
| IIB | 70 | 28 | 16 | 7 |
| IIIA | 73 | 0 | 7 | 6 |
| IIIB | 11 | 0 | 13 | 4 |
| IV | 26 | 0 | 1 | 0 |
| Survival status | ||||
| Alive | 317 | 76 | 90 | 22 |
| Dead | 181 | 51 | 43 | 21 |
| Survival time (Months, mean ± std) | 30.41 ± 30.04 | 42.39 ± 27.66 | 49.67 ± 31.70 | 53.53 ± 34.45 |
N indicates the number of tumor samples.